Previous Page  15 / 36 Next Page
Information
Show Menu
Previous Page 15 / 36 Next Page
Page Background

Page 42

Cancer Therapy & Biomarkers 2016

Day 2 December 06, 2016

Session Chair

Al Charest

Beth Israel Deaconess Medical Center Cancer Center, USA

Session Chair

Andrea Nicolini

University of Pisa, Italy

Sessions:

Anti-Cancer Drugs and Delivery | Biomarkers | Novel Approaches to Cancer

Therapeutics | Chemotherapy | Cancer and Lifestyle Connection | Cancer

Biomarkers | Cancer Cell Biology, Diagnosis and Applied Research

Session Introduction

Title:

Preoperative neutrophil to lymphocyte ratio predicts central compartment lymph nodes

metastasis in papillary thyroid microcarcinoma

Xiequn Xu,

Peking Union Medical College Hospital, China

Title:

Inhibitive effect of Non-viable derivatives of Clostridium sporogenes on colorectal cancer

cells

Madhura Satish Bhave,

Nanyang Technological University, Singapore

Title:

Breast carcinoma metastasis suppressor gene 1 (BRMS1): Update on its role as the

suppressor of cancer metastases in the context of combinatorial cancer treatment

Magdalena Kodura,

Karolinska Institute, Sweden

Title:

Anaemia in cancer patients undergoing radiotherapy and chemotherapy in National

Hospital Abuja, Nigeria

Chinedu S Aruah,

National Hospital Abuja, Nigeria

Title:

Simvastatin induces apoptosis of Osteosarcoma cells: A novel potential therapeutic

approach

Walied A Kamel,

Keio University, Japan

Title:

Decision-making of cancer patients about End-of-Life: The lived experience

Angela Katrina G Fonte,

Far Eastern University, Philippines

Title:

Endothelium-derived 5-Methoxytryptophan acts as a therapeutic biomarker for systemic

inflammation

Cheng Chin Kuo,

National Health Research Institutes, Taiwan

Title:

An

in vitro

evaluation of carmustine-loaded Nano-co-Plex for potential magnetically

targeted intranasal delivery to the brain for brain tumor management

Olufemi David Akilo,

University of the Witwatersrand, South Africa

Title:

How many cell death pathways that Doxorubicin can affect HepG2 cells?

Noor Mohammed,

7 goss croft birmingham, UK

Title:

Protection against oral mucositis in patients undergoing radiotherapy of the head and

neck with topical mucoadhesive gel containing Propolis

Vagner Rodrigues Santos,

Universidade Federal de Minas Gerais, Brazil